Brief: Thorne Healthtech Reaffirms Full-Year 2023 Guidance
11/05/2023 21:06
May 11 (Reuters) - Thorne Healthtech Q1 adjusted EPS USD 0.06. * Q1 sales USD 65.2 million * Q1 adjusted EBITDA USD 6.1 million * Q1 gross profit USD 34.3 million * Q1 EPS USD -0.01
Recent news on Thorne HealthTech
See all newsBrief: L Catterton And Thorne Healthtech, Inc. Announce Expiration Of Tender Offer
Brief: L Catterton And Thorne Healthtech Announce Expiration Of Tender Offer
Brief: Thorne Healthtech Received Notice Of Delisting From Nasdaq
Brief: Kirin Holdings To Sell All Of 29.1% Stake It Owns In Thorne Healthtech For About 23 Billion Yen - Nikkei
U.S. RESEARCH ROUNDUP- Celsius Holdings, RPT Realty, Thorne Healthtech